On Monday, in the course of current trade, Shares of Facebook, Inc. (NASDAQ:FB), dropped -1.38%, and is now trading at $81.01.
Facebook, is launching a new app for Google Android phones, called Facebook Lite, in an effort to expand its user base in emerging countries, according to TheStreet.
Arvind Bhatia, an analyst with Sterne Agee, said Facebook is one of several companies that are looking to break into and capitalize on new audiences that will become accessible once accessibility in emerging countries enhances. “It’s part of Facebook’s desire to reach as wide an audience worldwide as possible,” Bhatia said. TheStreet Reports.
Facebook, Inc. operates as a social networking company worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications.
During an Afternoon trade, Shares of Mylan N.V. (NASDAQ:MYL), dipped -0.49%, and is now trading at $73.78.
Mylan, declared the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg and Ethinyl Estradiol Tablets USP, 0.01 mg, which is the generic version of Teva’s Seasonique® Tablets. Mylan’s partner Famy Care Ltd. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg and Ethinyl Estradiol Tablets USP, 0.01 mg, had U.S. sales of about $160.7 million for the 12 months ending March 31, 2015, according to IMS Health.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
Shares of ECPM Holdings, LLC (NYSE:GI), during its Monday’s current trading session gained 8.56%, and is now trading at $18.45, hitting its highest level.
EndoChoice, declared the pricing of its initial public offering of 6,350,000 shares of its common stock at a price to the public of $15.00 per share. The offering is planned to close on June 10, 2015, subject to customary closing conditions. The underwriters for the offering will also have a 30-day option to purchase up to an additional 952,500 shares of EndoChoice common stock at the price to the public, less the underwriting discounts and commissions.
Based in the Atlanta, Georgia area, EndoChoice is a medtech company focused on the manufacturing and commercialization of platform technologies counting endoscopic imaging systems, devices and infection control products and pathology services for specialists screening, diagnosing and treating a wide range of gastrointestinal conditions, counting colon cancer.
Finally, Chipotle Mexican Grill, Inc. (NYSE:CMG), lost -0.58% Monday.
Chipotle Mexican Grill, declared that it will host a conference call to talk about second quarter 2015 financial results on Tuesday, July 21, 2015 at 4:30 PM Eastern time.
The conference call can be accessed live over the phone by dialing 1-888-378-4413 or for international callers by dialing 1-719-325-2444.
Chipotle Mexican Grill, Inc., together with its auxiliaries, develops and operates fast-casual and fresh Mexican food restaurants. As of April 21, 2015, it operated about 1,800 restaurants, counting 19 Chipotle restaurants and 10 ShopHouse Southeast Asian Kitchen restaurants.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
